Identifying early inflammatory changes in monocyte derived macrophages from a population with IQ discrepant episodic memory by Downer, Eric J. et al.
Title Identifying early inflammatory changes in monocyte derived
macrophages from a population with IQ discrepant episodic memory
Author(s) Downer, Eric J.; Jones, Raasay S.; McDonald, Claire L.; Greco,
Eleonora; Brennan, Sabina; Connor, Thomas J.; Robertson, Ian H.;
Lynch, Marina A.
Publication date 2013
Original citation Downer EJ, Jones RS, McDonald CL, Greco E, Brennan S, Connor TJ,
et al. (2013) Identifying Early Inflammatory Changes in Monocyte-
Derived Macrophages from a Population with IQ-Discrepant Episodic
Memory. PLoS ONE 8(5): e63194. doi:10.1371/journal.pone.0063194
Type of publication Article (peer-reviewed)
Link to publisher's
version
http://dx.doi.org/10.1371/journal.pone.0063194
Access to the full text of the published version may require a
subscription.
Rights @ 2013 Downer et al. This is an open access article distributed
under the terms of the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in
any medium, provided the original author and source are credited
http://creativecommons.org/licenses/by/4.0/
Item downloaded
from
http://hdl.handle.net/10468/2380
Downloaded on 2017-02-12T11:20:11Z
Identifying Early Inflammatory Changes in Monocyte-
Derived Macrophages from a Population with IQ-
Discrepant Episodic Memory
Eric J. Downer1*.
¤
, Raasay S. Jones1., Claire L. McDonald1, Eleonora Greco2, Sabina Brennan2,
Thomas J. Connor1, Ian H. Robertson2, Marina A. Lynch1
1 Trinity College Institute of Neuroscience and Physiology Department, Trinity College, Dublin, Ireland, 2 Trinity College Institute of Neuroscience and School of
Psychology, Trinity College, Dublin, Ireland
Abstract
Background: Cells of the innate immune system including monocytes and macrophages are the first line of defence against
infections and are critical regulators of the inflammatory response. These cells express toll-like receptors (TLRs), innate
immune receptors which govern tailored inflammatory gene expression patterns. Monocytes, which produce pro-
inflammatory mediators, are readily recruited to the central nervous system (CNS) in neurodegenerative diseases.
Methods: This study explored the expression of receptors (CD11b, TLR2 and TLR4) on circulating monocyte-derived
macrophages (MDMs) and peripheral blood mononuclear cells (PBMCs) isolated from healthy elderly adults who we
classified as either IQ memory-consistent (high-performing, HP) or IQ memory-discrepant (low-performing, LP).
Results: The expression of CD11b, TLR4 and TLR2 was increased in MDMs from the LP group when compared to HP cohort.
MDMs from both groups responded robustly to treatment with the TLR4 activator, lipopolysaccharide (LPS), in terms of
cytokine production. Significantly, MDMs from the LP group displayed hypersensitivity to LPS exposure.
Interpretation: Overall these findings define differential receptor expression and cytokine profiles that occur in MDMs
derived from a cohort of IQ memory-discrepant individuals. These changes are indicative of inflammation and may be
involved in the prodromal processes leading to the development of neurodegenerative disease.
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Introduction
Neuroinflammatory changes develop with age and are a feature
of most neurodegenerative diseases including Alzheimer’s disease
(AD). Epidemiological studies indicate that long-term non-
steroidal anti-inflammatory treatment reduces the risk of develop-
ing AD [1] suggesting that inflammatory processes may contribute
to very early changes in the pathogenesis of the disease. The
inflammatory changes in the central nervous system (CNS) in
normal ageing and AD are characterised by microglial activation
with resultant changes in microglial phagocytic activity and
neurotoxic consequences [2–4]; the evidence indicates that some
of these CNS changes have systemic parallels. The number of
blood-derived monocytes is increased in AD patients [5], and it
has been reported that circulating monocytes express specific cell
adhesion molecules (CAMs) that are altered with age, and in
patients with AD and Mild Cognitive Impairment (MCI) [6,7].
Interestingly, circulating monocytes readily infiltrate the brain in
murine models of AD [8,9] and evidence indicates that blood-
borne monocytes can act as amyloid phagocytes and may be
involved in amyloid-b (Ab) clearance [10]. These findings,
alongside others which show that monocytes, in addition to in vitro
differentiated macrophages, express several AD-related genes [11],
suggest that circulating monocytes may be a valuable model
system in assessing the role of microglial cells in the pathogenesis of
neurodegenerative conditions.
Human monocytes express an array of CAMs and receptors
that are crucial for cell-cell and cell-matrix interactions, transmi-
gration and innate immune responses. Of these, CD11b is a
receptor for intercellular adhesion and is a phenotypic monocytic
cell marker, the expression of which increases with age, indicating
a more activated phenotype [6]. Monocytes/macrophages also
express a diverse array of toll-like receptors (TLRs), a family of
signalling pattern recognition receptors that mediate innate
immunity by recognising conserved motifs of microbial origin
known as pathogen-associated molecular patterns (PAMPs) and
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endogenous damage-associated molecular patterns (DAMPs) that
are released by injured tissue [12]. Human blood monocytes
express TLR1, TLR2, TLR4, TLR5, TLR6, TLR8, and TLR9
mRNA, with TLR2 and TLR4 being the most highly expressed
[13]. TLRs continue to emerge as key players in CNS diseases and
much data link TLRs with AD pathology, with polymorphism in
the tlr2 and tlr4 gene linked with the disease [14]. The classical
monocyte marker, CD14, a glycosylphosphatidyl inositol (GPI)-
anchored myeloid glycoprotein, acts as a co-receptor for TLRs
and is responsible for the uptake of Gram-negative bacterial
lipopolysaccharide (LPS) via macropinocytosis [15]. Indeed,
TLR4 acts as the primary signalling receptor for LPS [16], with
TLR2 further required for LPS-induced TLR4 signalling [17].
In an attempt to quantify relative decline and explore
discrepancies between targeted cognitive domains that are central
to ageing (e.g. episodic memory) and a proxy measure of lifetime
cognitive capacity, we have identified a group of otherwise healthy
adults who we classify as low performers (LP) because their
memory performance is discrepant with their estimated IQ. The
advantage of adopting such an approach is threefold. First, it
allows quantification of true age-related changes in the strength or
weakness of memory relative to an estimate of lifetime cognitive
capacity. Second, it allows one to dissociate domain-specific
changes in memory function. Third, it allows classification of
individuals as high or low memory performers based on
standardised measures of memory relative to IQ that can be
utilised, not only in research, but also in a clinical setting. The
purpose of the study was to compare the expression of receptors
(CD11b, TLR2 and TLR4) on circulating monocyte-derived
macrophages (MDMs) and the response of these cells to LPS in
samples prepared from the LP cohort and a cohort which we
classified as IQ memory-consistent (high-performing, HP) individ-
uals. We show that MDMs isolated from the LP group display
enhanced expression of CD11b, TLR2 and TLR4, compared to
the HP group. We further show that treatment of MDMs with
LPS promoted pro-inflammatory cytokine production in HP and
LP groups, but that the effect was exacerbated in MDMs prepared
from the LP group.
Methods
Participants
Adults (35 female, 12 male) with a mean age of 71.5 years (range
of 65 to 82) were recruited from the older adult participant panel
of the Trinity College Institute of Neuroscience, Dublin, Ireland.
Participants were assigned to low and high performing sub-groups
(LP and HP respectively) based on their memory performance
relative to an estimate of their intelligence. Z-scores were used to
relate their performance on the Wechsler Memory Scale story
recall test [WMS III UK; 18] to their scores on The National
Adult Reading Test [NART; 19]. Participants were defined as LP
if they scored more than 0.75 standard deviations below their
NART-estimated IQ on the WMS. All other participants were
classified as HP. This approach yielded 35 HPs (26 female, 9 male)
with a mean age of 71.9 (SD=4.7) and 12 LPs (9 female, 3 male)
with a mean age of 71.1 (SD=4.8). No significant difference was
observed in Mini Mental State Exam (MMSE) scores between the
two groups (Table 1).
Participants received reimbursement of travel expenses to the
maximum value of J20. This study was approved by the Ethics
Committee of the School of Psychology at Trinity College Dublin,
and all participants provided informed consent. All participants
completed a detailed questionnaire about their own health and
current medications, as well as any relevant health issues in their
family. Participants who had a history of head injury, stroke,
epilepsy, neurological conditions, major psychiatric disorder, heart
attack or diabetes were excluded from the study.
Neuropsychological Assessment
A battery of tests was administered in one session, and focused
on memory and executive function. The MMSE was used as a
screening measure. The NART was used as a proxy measure of
general intellectual status. Memory was assessed using 3 subtests of
Wechsler Memory Scale: Logical Memory I and II Verbal Paired
Associates I and II Visual Reproduction I and II.
Preparation of MDMs
Human PBMCs were prepared from heparinised venous whole
blood samples (50 ml per donor) from HP and LP individuals by
density separation over LymphoprepTM (Axis-Shield, Norway).
Plasma samples were separated following centrifugation, aliquoted
and stored at –80uC. CD14+ monocytes were isolated from
PBMCs using positive selection with MACS microbeads (Miltenyi
Biotec, Germany) and an autoMACS cell sorting instrument using
a method which results in up to 95% purity as estimated by flow
cytometry [20]. The mean percentage monocytes in PBMCs from
HP and LP groups was 20.561.0 and 18.4861.7, respectively
(P=0.289; 2-tailed unpaired t-test). In this study, CD14+ cells,
obtained from PBMCs following MACS sorting, were seeded
(66105 cells/ml) on 24-well plates and cultured in RPMI
supplemented with FBS (10%), antibiotics and human granulocyte
macrophage colony-stimulating factor (10 ng/ml; R&D Systems,
UK) for 7 days. At the end of this period, cells were assessed again
by flow cytometry; 90.2% of the cells were CD14+ (Figure S1),
which is consistent with previous studies that have been shown to
yield .85–92% CD14+ cells [20–22]. We refer to these cells as
MDMs in the present study.
Flow Cytometry
Freshly-isolated PBMCs and MDMs were washed 3 times in
FACS buffer (2% FBS, 0.1% NaN3 in PBS) and blocked for
20 min at 4uC with purified human IgG (1 mg/ml in FACS
buffer; Sigma, UK). Cells were incubated with anti-human
CD11b-APC (clone ICRF44), anti-human TLR2-FITC (clone
T2.5) and anti-human TLR4-PE-Cy7 (clone HTA125) (all at
1:100 in FACS buffer; Biosciences, UK). A minimum of 300,000
events were collected and the percentage positive staining for each
cellular target was calculated. Total viable PBMCs were initially
gated via forward and side scatter (demonstrated in Figure S2) and
Table 1. Demographic of subjects.
HP LP
N 35 12
Age (years; mean 6 SD) 71.964.7 71.164.8
Sex (F/M) 26/9 9/3
MMSE 27.462.8 26.962.6
Premorbid IQ 1.1360.37 1.2060.29
Delayed verbal memory 1.4360.82 20.0660.72*
Premorbid IQ was measured by the National Adult Reading Test (NART).
Delayed verbal memory was determined by the Logical Memory subtest of the
Wechsler Memory Scale.
*HP versus LP; memory performance was less than 0.75 z-score below their
estimated premorbid IQ.
doi:10.1371/journal.pone.0063194.t001
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doublets were excluded via forward scatter versus pulse width
signal. CD14+ monocytes, isolated from PBMCs using positive
selection with MACS microbeads (85–92% purity [22]), were
differentiated to MDMs over 7 days, and viable MDMs (90.2%
CD14+ cells) gated via forward and side scatter. Flow cytometric
analysis of CD11b+, TLR2+ and TLR4+ cells in PBMCs and
MDMs was performed on a DAKO CyAN ADP 7 colour flow
cytometer (DAKO Cytomation, UK) with Summit v4.3 software
and analysed with FloJo v7.6.5 software, with gating set on
appropriate type matched IgG1 k isotype controls and fluores-
cence-minus one (FMO) controls prepared from LP and HP
cohorts. Non-specific staining was further minimised by incubating
cells from HP and LP groups in purified human IgG. Instrument
compensation and cell subset gates were set based on unstained,
isotype and FMO controls, which were all based on viable forward
versus side scatter gates.
Real-time PCR
MDMs were stimulated with LPS (100 ng/ml) and after 24 h
RNA was extracted using a NucleoSpinH RNAII isolation kit
(Macherey-Nagel Inc., Germany). The concentration of LPS used
is in line with those used in various inflammatory paradigms in
human monocytes and macrophages [23–25]. The concentration
of RNA was determined using a UV/Vis spectrophotometer
(Beckman Coulter Inc., Ireland). cDNA synthesis was performed
on 1 mg RNA using a High Capacity cDNA RT Kit (Applied
Biosystems, USA) according to the manufacturer’s instructions.
Equal amounts of cDNA were used for RT-PCR amplification.
Real-time PCR primers were delivered as ‘‘TaqmanH Gene
Expression Assays’’ containing forward and reverse primers, and a
FAM-labeled MGB Taqman probe for each gene (Applied
Biosystems, USA). Primers used were as follows: CD11b, TLR2
and TLR4 (TaqmanH Gene Expression Assay no.
Hs00355885_m1, Hs00610101_m1 and Hs00152937_m1, respec-
tively). A 1 in 4 dilution of cDNA was prepared and real-time PCR
performed using an Applied Biosystems 7300 Real-time PCR
System. cDNA was mixed with qPCRTM Mastermix Plus (Applied
Biosystems, USA) and the respective gene assay in a 25 ml volume
(10 ml of diluted cDNA, 12.5 ml TaqmanH Universal PCR
Mastermix, 1.25 ml target primer and 1.25 ml GAPDH). Human
GAPDH was used as an endogenous control and expression was
conducted using a gene expression assay containing forward and
reverse primers and a VIC-labeled MGB Taqman probe
(#4326317E; Applied Biosystems, USA). Samples were run in
duplicate and 40 cycles were run as follows: 10 min at 95uC and
for each cycle, 15 s at 95uC and 1 min at 60uC. Gene expression
was calculated relative to the endogenous control and analysis was
performed using the 22DDCT method. In all experiments no
change in relative GAPDH mRNA expression between treatment
groups was observed.
Cytokine Analysis in Culture Supernatants
MDMs were stimulated with LPS (100 ng/ml; 24 h) and
supernatants were assessed for tumor necrosis factor (TNF)a, IL-
6, IL-10 and IL-12p70 production using a human pro-inflamma-
tory-7-plex assay (MesoScale Discovery, USA) according to
manufacturer’s instructions. Briefly, plates were blocked in Diluent
2 for 30 min at room temperature and duplicate samples and
standards (0–10,000 pg/ml) added for 2 h at room temperature
with vigorous shaking. Detection antibody solution was added for
2 h at room temperature with vigorous shaking. Plates were
washed again and read buffer was added to the plate. The plate
was read immediately using a Mesoscale Sector Imager plate
reader and pro-inflammatory cytokine concentrations in test
samples were evaluated with reference to the standard curve
prepared using the 7-plex calibrator blend.
C-reactive Protein (CRP) Measurement in Plasma
Plasma samples from HP and LP groups were analysed for
concentrations of CRP by ELISA (Duoset, R&D Systems, UK)
according to manufacturer’s instructions.
Statistical Analysis
Data were analysed using a Student’s t-test for independent
means or two-way analysis of variance (ANOVA) as appropriate.
When analysis by ANOVA indicated significance (P,0.05), the
post hoc Student Newman–Keuls test was used. Data are
expressed as means 6 standard errors of the mean (SEM).
Results
Human MDMs Isolated from the LP Group Display
Enhanced Expression of CD11b, TLR2 and TLR4,
Compared to HPs
Since neurological symptoms are often exacerbated by infection
[26], we initially assessed plasma levels of the inflammatory
reactant CRP in plasma from HP and LP groups. No significant
difference in plasma CRP concentration was found between
groups (Figure 1A). PBMCs predominantly constitute lymphocytes
and monocytes, with lower numbers of natural killer (NK) and
dendritic cells. CD11b is an adhesion molecule primarily
expressed on the surface of monocytes, but also on activated
lymphocytes and a subset of NK cells, where it mediates leukocyte
adhesion and migration to orchestrate an inflammatory response
[27]. Indeed, CD11b expression is upregulated by many
inflammatory mediators including cytokines [28]. CD11b expres-
sion was unchanged on PBMCs isolated from the HP and LP
groups (Figure 1B, C, P=0.45) and no difference in MDM CD14
mRNA was observed between groups (Figure 1D) suggesting that
differentiation of monocytes to macrophages was similar in LP and
HP individuals. However, the percentage of CD11b+ cells in the
MDM preparation was significantly greater in the LP group,
compared with the HP group (Figure 1E, F, P,0.05) and the
CD11b staining intensity was also higher on MDMs from the LP
group, compared with the HP group (Figure 1G, P,0.05).
Although CD11b mRNA was also enhanced in MDMs from the
LP, compared with the HP, group the difference did not reach
statistical significance (Figure 1H, P=0.19). Since macrophages
and other cells of the innate immune system recognise distinct
microbial products via TLRs, we next assessed the expression of
TLR2 and TLR4 since they are specifically implicated in
inflammatory changes associated with neurodegeneration
[14,29]. TLR2 expression on CD11b+ cells was similar on PBMCs
isolated from the HP and LP groups (Figure 1I, J) but expression in
MDMs from the LP group was higher than the HP group,
although it did not reach statistical significance (Figure 1K, L,
P=0.056); MFI values for the HP and LP groups were 88.1 and
77.2 respectively. TLR2 mRNA was significantly greater in
MDMs prepared from the LP group compared with the HP group
(P,0.05; Figure 1M). TLR4 expression on CD11b+ cells was
similar on PBMCs isolated from the HP and LP groups (Figure 1N,
O) but expression on MDMs from the LP group was significantly
greater than from the HP group (P,0.05; Figure 1P, Q); MFI
values for the HP and LP groups were 37.1 and 28.3 respectively.
TLR4 mRNA was significantly greater in MDMs prepared from
the LP group compared with the HP group (P,0.05; Figure 1R).
Overall, this indicates that differentiated MDMs, but not freshly
Inflammatory Changes in MDMs from LPs
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prepared PBMCs, isolated from the LP cohort display elevated
expression of CD11b and TLR2/4.
MDMs from the LP Group are Hypersensitive to LPS
Since TLR4 acts as the primary signalling receptor for Gram-
negative bacterial LPS [16] and because TLR4 expression was
increased in MDMs prepared from the LP cohort, we examined
the effect of LPS on cytokine production in MDMs from HP and
LP groups. Production of the cytokines TNFa, IL-6, IL-10 and IL-
12p70 was similar in unstimulated MDMs from HP and LP
groups (Figure 2). However, LPS significantly increased cytokine
production in MDMs from both groups, and importantly the
production of TNFa (Figure 2A), IL-6 (Figure 2B), IL-10
(Figure 2C) and IL-12p70 (Figure 2D) was exacerbated in MDMs
prepared from the LP group, compared with the HP group
(P,0.05). This indicates that MDMs prepared from the LP group
are hyper-responsive to LPS, at least in terms of cytokine
production, and the increase in TLR4 expression provides a
plausible mechanism for this effect.
Discussion
We investigated the expression of TLR2 and 4, and the impact
of in vitro treatment with LPS on the production of cytokines in
MDMs prepared from an IQ memory–discrepant LP cohort,
compared with an IQ memory-consistent HP cohort. The
significant finding is that MDMs from the LP group expressed
higher levels of TLR2 and TLR4, as well as CD11b, and exhibited
a more robust response to LPS, than MDMs from the HP group.
Ageing is associated with defects in both the innate and adaptive
arms of the immune system. Indeed, elderly individuals display
reduced B cell production [30] and T cell memory [31], ensuring
greater susceptibility than young individuals to bacterial and viral
infection. Much data also indicate that ageing affects cells of the
innate immune system, particularly associated with alterations in
neutrophil [32] and monocyte/macrophage phagocytic capacity
[33], and ability to produce cytokines and chemokines [33].
Overall, cumulative data indicates that defective innate immunity
is associated with advancing age. Intermediate stages between
normal ageing and dementia are recognised by several classifica-
tion systems; the best recognised are the several clinical subtypes of
MCI, a preclinical stage of AD [34]. The lack of diagnostic tools
which enable early detection of conditions like MCI and/or AD is
a major stumbling block for treatment of disease and a method of
detecting early changes in cognitive function relative to previous
levels would be a significant advance. Structural changes which
are indicative of conversion from normal ageing to MCI and AD
have been identified using image analysis [35]. In addition, a
number of peripheral blood-based biomarkers have been suggest-
ed, however the most compelling data have been obtained from
analysis of cerebrospinal fluid (CSF) in which the ratio of Ab/
phosphorylated tau combined with total tau levels yielded a
positive predictive value in terms of conversion from MCI to AD
[36].
Myeloid cells, constituting blood-borne monocytes, tissue
resident macrophages and parenchymal microglia, have defined
functions in neurodegenerative diseases. Monocytes and macro-
phages not only share the same origin with microglia in the brain,
but also have the same antigens, functions, and regulatory
mechanisms [37]. Much research has focused on characterising
the neurodegenerative role of microglial cells which accumulate at
senile plaques in AD [9], secreting proteolytic enzymes that
degrade Ab [38] and expressing receptors that promote the
phagocytosis of Ab [39]. Monocytes and macrophages are
professional phagocytic cells and central players in orchestrating
the innate immune response. Monocytes/macrophages have pro-
inflammatory and cytotoxic properties, with the proclivity to
produce inflammatory molecules such as TNFa and inducible
nitric oxide synthase [37]. Blood-borne monocytes are highly
mobile and rapidly recruit to inflamed CNS tissue during bacterial
infection [40], autoimmune disorders [41] and neurodegenerative
disease [8]. Indeed, circulating monocytes can infiltrate the CNS
parenchyma and differentiate into microglia [42], where they are
important for clearing amyloid and limiting its deposition in
murine models of AD [43]. Furthermore, macrophages display an
activated phenotype in neurodegenerative disease, typified by
increased expression of cell surface markers such as CD11b [44],
CNS infiltration [45] and enhanced production of inflammatory
cytokines [46].
Here we show that expression of TLR4 was greater in MDMs
obtained from the LP cohort compared with the HP cohort and,
consistently, that incubation of cells from the LP cohort responded
more robustly to LPS with significantly greater production of
TNF, IL-6 and IL-12 than that produced by MDMs from the HP
group. MDMs are a type I or classically activated (M1)
macrophage that display a pro-inflammatory phenotype [47].
MDMs are considered a peripheral counterpart of microglia, as
they share the same progenitor and antigen markers, and they
have similar biological behaviours that mirror microglial function
in the brain [48,49]. Previous evidence has shown that they
produce inflammatory cytokines in response to LPS treatment [50]
and that they express TLR4 [51], which is confirmed here.
Interestingly monocytes from older, compared with younger,
individuals have higher intracellular levels of TNF both at baseline
Figure 1. Enhanced CD11b, TLR2 and TLR4 expression in MDMs from LPs. A) Plasma isolated from HP and LP groups displayed comparable
levels of CRP. Data are presented as mean6 SEM and represent triplicate determinations from 35 and 12 samples per HP and LP groups, respectively.
B) CD11b expression on PBMCs was unchanged between HP and LP subjects. C) Representative plots of CD11b+ cells in PBMC populations. Numbers
beside gated areas indicate the percentage positive cells in that area. D) CD14 expression in MDMs was similar in LP and HP individuals following 7
days in culture. E) Percentage CD11b expression was increased in MDMs derived from the LP group, compared with the HP group (P,0.05). F)
Representative dot plots of CD11b+ cells in MDMs (with values beside gated areas indicating the percentage positive cells in that area) show marked
differences between cohorts. G) CD11b mean fluorescence intensity on MDMs was increased in the LP group compared with the HP group (P,0.05).
H) CD11b mRNA in MDMs derived from the LP group was slightly, though not significantly, greater than values from the HP group (P= 0.19). I) TLR2
expression on CD11b+ PBMCs was similar in HP and LP groups and this is also shown in the representative dot plots of TLR2+ cells (J) which indicate
the percentage positive cells. K) TLR2 expression on CD11b+ MDMs was increased in the LP group, compared to the HP group (P= 0.056) and this is
also shown in the representative dot plots of TLR2+ cells (L) which indicate the percentage positive cells. M) TLR2 mRNA expression was increased on
MDMs derived from the LP group compared with the HP group (P,0.05). N) TLR4 expression on CD11b+ PBMCs was similar in HP and LP groups and
this is also shown in the representative dot plots of TLR4+ cells (O) which indicate the percentage positive cells. P) TLR4 expression on CD11b+ MDMs
was increased in the LP group compared with the HP group (P,0.05) and this is also shown in the representative dot plots of TLR4+ cells (Q) which
indicate the percentage positive cells. R) TLR4 mRNA expression on MDMs was increased in the LP group compared with the HP group (P,0.05). Data
are expressed as (B, E, I, K, N, P) mean percentage or fluoresence (G) expression 6 SEM, or (D, H, M, R) mean relative expression 6 SEM, of duplicate
determinations in 35 and 12 samples per HP and LP groups, respectively.
doi:10.1371/journal.pone.0063194.g001
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and following LPS stimulation [6], while pro-inflammatory
cytokine [52] and chemokine [53,54] levels are elevated in
peripheral blood monocytes isolated from the elderly after LPS
stimulation. In addition, PBMCs from AD patients have been
reported to produce enhanced levels of IL-6 following LPS
stimulation compared with controls [55]. These findings suggest
that monocyte function is dysregulated both with age and in AD,
but the present study significantly extends these observations to
show that similar changes can be picked up in MDMs prepared
from a group of otherwise healthy adults whose memory
performance is discrepant with their estimated IQ.
CD11b is a receptor for intercellular adhesion molecule family
members CD54, CD102 and CD50, enabling leukocyte adhesion
and migration to mediate the inflammatory response [27]. CD11b
is also a typical monocyte/macrophage marker, the expression of
which is increased following activation [44]. Indeed, CD11b
expression is increased in monocytes from aged individuals [6] and
on microglial cells in aged animals [3]. Furthermore the number of
CD11b+ activated microglia is increased in mouse models of AD
[56] and MS [57]. The present data indicate that CD11b
expression was enhanced in MDMs, but not PBMCs, from the LP
cohort, indicating that these cells displayed an enhanced activated
phenotype. This cell type-specific effect indicates that altering the
phenotype of human monocytes in vitro may provide a mechanism
which identifies alterations of myeloid cell function in cohorts with
the most subtle cognitive changes. It is of interest to note that
modifications of macrophage phenotype have been suggested in
conditions where clear pathology is identified, i.e. in chronic
inflammatory conditions [58], autoimmune disorders [59] and AD
[60].
Human monocytes express an array of TLRs [13] and our data
indicate that both CD11b+ PBMCs and MDMs express TLR2
and TLR4. In the present study we focused on examining
expression of TLR2 and TLR4 since much evidence indicates the
role of these receptors in neurodegenerative conditions. Mono-
cytes derived from elderly individuals display defective TLR
signalling, particularly TLR1/2, with further decreases in relative
TLR1 and TLR4 expression determined on peripheral blood
monocytes from older subjects [6,61]. TLR2/42/2 mice are
protected from cognitive impairment following Ab immunisation
[29] with polymorphism in the tlr2 and tlr4 gene linked with AD
[14]. Knockout studies suggest differential effects of TLRs on AD
progression; deletion of CD14, a co-receptor for TLR2/4, reduces
plaque burden in a murine AD model [62], but deletion of MyD88
enhances memory deficits [63]. Importantly, evidence indicates
that Ab binds microglial TLR2 and 4 [64] suggesting that TLRs
function as members of the Ab receptor complex. Our findings
indicate that the expression of TLR2 and TLR4 is increased in
Figure 2. MDMs from LPs are hypersensitive to LPS. LPS (100 ng/ml; 24 h) increased A) TNFa, B) IL-6, C) IL-10 and D) IL-12p70 in MDMs
prepared from HPs and LPs. The production of each cytokine was exaggerated in MDMs prepared from LPs, compared to HPs (P,0.05). Data are
presented as mean 6 SEM and represent duplicate determinations from 35 and 12 samples per HP and LP groups, respectively.
doi:10.1371/journal.pone.0063194.g002
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MDMs from the LP group, compared with the HP group. Since
increased TLR expression does not occur on monocytes in healthy
elderly individuals [6], while increased expression of TLR2 and
TLR4 has been reported in PBMCs from patients with late-onset
AD [65], the data may suggest a role for increased TLR expression
in progression from the mildest manifestation of episodic memory
loss to more profound cognitive decline.
Our results identify changes in the expression of receptors
CD11b, TLR2 and TLR4 on MDMs isolated from a unique
cohort of IQ memory-discrepant older adults. Consistent with the
increased expression of TLR4, stimulation with LPS promoted
enhanced cytokine production in MDMs from this LP group,
compared with the HP IQ memory-consistent group. It is
important to note that bacterial and(or) viral infections are
associated with reduced cognitive performance [26], but no
differences in plasma concentrations of CRP were identified
between the cohorts in this study. These peripheral cell changes,
which are indicative of inflammation, may provide a biological
substrate indicative of the earliest discernible changes in episodic
memory decline which may be a precursor to more profound
changes that are associated with the development of neurodegen-
erative disease.
Supporting Information
Figure S1 Flow cytometric analysis of MDMs. Flow
cytometric analysis of MDMs and selection of CD14+ cells.
CD14+ monocytes were separated from PBMCs using a MACS
sorter. The CD14+ monocytes were cultured for 7 days with GM-
CSF (10 ng/ml), and stained with a CD14 antibody to determine
purity by flow cytometry. Gates were made using the isotype
controls. After one week in culture 90.2% of cells were CD14+.
(TIF)
Figure S2 Flow cytometric analysis of PBMCs. A) Flow
cytometric analysis of PBMCs and selection of live cells. PBMC
gate location determined via forward/side scatter analysis of
PBMCs. B) Using a logical gating strategy, live PBMCs gated for
CD11b.
(TIF)
Acknowledgments
Our co-author and colleague, Tom Connor, passed away on 26th
February 2013; we would like to dedicate this publication to his memory.
The authors gratefully acknowledge the support of Science Foundation
Ireland (07/IN.1/B949) and Atlantic Philanthropies (Neuroenhancement
for Independence in Elder Lives (NIEL). The authors would also like to
thank L. Penny for her assistance with phlebotomy, and B. Moran for
technical help with FACS.
Author Contributions
Conceived and designed the experiments: EJD RSJ TJC IHR MAL.
Performed the experiments: EJD RSJ EG SB. Analyzed the data: EJD RSJ
CM EG SB. Wrote the paper: EJD.
References
1. McGeer PL, Schulzer M, McGeer EG (1996) Arthritis and anti-inflammatory
agents as possible protective factors for Alzheimer’s disease: a review of 17
epidemiologic studies. Neurology 47: 425–432.
2. Cribbs DH, Berchtold NC, Perreau V, Coleman PD, Rogers J, et al. (2012)
Extensive innate immune gene activation accompanies brain aging, increasing
vulnerability to cognitive decline and neurodegeneration: a microarray study.
J Neuroinflammation 9: 179.
3. Ojo B, Rezaie P, Gabbott PL, Cowely TR, Medvedev NI, et al. (2011) A neural
cell adhesion molecule-derived peptide, FGL, attenuates glial cell activation in
the aged hippocampus. Exp Neurol 232: 318–328.
4. Perlmutter LS, Scott SA, Barron E, Chui HC (1992) MHC class II-positive
microglia in human brain: association with Alzheimer lesions. J Neurosci Res 33:
549–558.
5. Lunnon K, Ibrahim Z, Proitsi P, Lourdusamy A, Newhouse S, et al. (2012)
Mitochondrial dysfunction and immune activation are detectable in early
Alzheimer’s disease blood. J Alzheimers Dis 30: 685–710.
6. Hearps AC, Martin GE, Angelovich TA, Cheng WJ, Maisa A, et al. (2012)
Aging is associated with chronic innate immune activation and dysregulation of
monocyte phenotype and function. Aging Cell.
7. Hochstrasser T, Weiss E, Marksteiner J, Humpel C (2010) Soluble cell adhesion
molecules in monocytes of Alzheimer’s disease and mild cognitive impairment.
Exp Gerontol 45: 70–74.
8. Stalder AK, Ermini F, Bondolfi L, Krenger W, Burbach GJ, et al. (2005)
Invasion of hematopoietic cells into the brain of amyloid precursor protein
transgenic mice. J Neurosci 25: 11125–11132.
9. Simard AR, Soulet D, Gowing G, Julien JP, Rivest S (2006) Bone marrow-
derived microglia play a critical role in restricting senile plaque formation in
Alzheimer’s disease. Neuron 49: 489–502.
10. El Khoury J, Toft M, Hickman SE, Means TK, Terada K, et al. (2007) Ccr2
deficiency impairs microglial accumulation and accelerates progression of
Alzheimer-like disease. Nat Med 13: 432–438.
11. Wahle T, Thal DR, Sastre M, Rentmeister A, Bogdanovic N, et al. (2006)
GGA1 is expressed in the human brain and affects the generation of amyloid
beta-peptide. J Neurosci 26: 12838–12846.
12. Vezzani A, Maroso M, Balosso S, Sanchez MA, Bartfai T (2011) IL-1 receptor/
Toll-like receptor signaling in infection, inflammation, stress and neurodegen-
eration couples hyperexcitability and seizures. Brain Behav Immun.
13. Muzio M, Bosisio D, Polentarutti N, D’Amico G, Stoppacciaro A, et al. (2000)
Differential expression and regulation of toll-like receptors (TLR) in human
leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 164:
5998–6004.
14. Wang LZ, Tian Y, Yu JT, Chen W, Wu ZC, et al. (2011) Association between
late-onset Alzheimer’s disease and microsatellite polymorphisms in intron II of
the human toll-like receptor 2 gene. Neurosci Lett 489: 164–167.
15. Poussin C, Foti M, Carpentier JL, Pugin J (1998) CD14-dependent endotoxin
internalization via a macropinocytic pathway. J Biol Chem 273: 20285–20291.
16. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate
immunity. Cell 124: 783–801.
17. Good DW, George T, Watts BA 3rd (2012) Toll-like receptor 2 is required for
LPS-induced Toll-like receptor 4 signaling and inhibition of ion transport in
renal thick ascending limb. J Biol Chem 287: 20208–20220.
18. Wechsler D (1998) WMS-III uk Administration and Scoring Manual (Third ed.):
The Psychological corporation Limited.
19. Nelson HE (1982) National Adult Reading Test. Windsor UK: NFER-Nelson.
20. Andreani G, Celentano AM, Solana ME, Cazorla SI, Malchiodi EL, et al. (2009)
Inhibition of HIV-1 replication in human monocyte-derived macrophages by
parasite Trypanosoma cruzi. PLoS One 4: e8246.
21. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, et al. (2004)
Human IL-23-producing type 1 macrophages promote but IL-10-producing
type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad
Sci U S A 101: 4560–4565.
22. Rowan AG, Fletcher JM, Ryan EJ, Moran B, Hegarty JE, et al. (2008) Hepatitis
C virus-specific Th17 cells are suppressed by virus-induced TGF-beta.
J Immunol 181: 4485–4494.
23. Wehrhahn J, Kraft R, Harteneck C, Hauschildt S (2010) Transient receptor
potential melastatin 2 is required for lipopolysaccharide-induced cytokine
production in human monocytes. J Immunol 184: 2386–2393.
24. Schilling E, Wehrhahn J, Klein C, Raulien N, Ceglarek U, et al. (2012)
Inhibition of nicotinamide phosphoribosyltransferase modifies LPS-induced
inflammatory responses of human monocytes. Innate Immun 18: 518–530.
25. Wei W, Wang D, Shi J, Xiang Y, Zhang Y, et al. (2010) Tumor necrosis factor
(TNF)-related apoptosis-inducing ligand (TRAIL) induces chemotactic migra-
tion of monocytes via a death receptor 4-mediated RhoGTPase pathway. Mol
Immunol 47: 2475–2484.
26. Perry VH, Cunningham C, Holmes C (2007) Systemic infections and
inflammation affect chronic neurodegeneration. Nat Rev Immunol 7: 161–167.
27. Springer TA (1990) Adhesion receptors of the immune system. Nature 346: 425–
434.
28. Mazzone A, Ricevuti G (1995) Leukocyte CD11/CD18 integrins: biological and
clinical relevance. Haematologica 80: 161–175.
29. Vollmar P, Kullmann JS, Thilo B, Claussen MC, Rothhammer V, et al. (2010)
Active immunization with amyloid-beta 1–42 impairs memory performance
through TLR2/4-dependent activation of the innate immune system. J Immunol
185: 6338–6347.
30. Allman D, Miller JP (2005) The aging of early B-cell precursors. Immunol Rev
205: 18–29.
31. Weng NP (2006) Aging of the immune system: how much can the adaptive
immune system adapt? Immunity 24: 495–499.
32. Fulop T, Larbi A, Douziech N, Fortin C, Guerard KP, et al. (2004) Signal
transduction and functional changes in neutrophils with aging. Aging Cell 3:
217–226.
Inflammatory Changes in MDMs from LPs
PLOS ONE | www.plosone.org 7 May 2013 | Volume 8 | Issue 5 | e63194
33. Sebastian C, Espia M, Serra M, Celada A, Lloberas J (2005) MacrophAging: a
cellular and molecular review. Immunobiology 210: 121–126.
34. DeCarli C (2003) Mild cognitive impairment: prevalence, prognosis, aetiology,
and treatment. Lancet Neurol 2: 15–21.
35. Rami L, Sole-Padulles C, Fortea J, Bosch B, Llado A, et al. (2012) Applying the
new research diagnostic criteria: MRI findings and neuropsychological
correlations of prodromal AD. Int J Geriatr Psychiatry 27: 127–134.
36. Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, et al. (2009)
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive
impairment. JAMA 302: 385–393.
37. Shi C, Pamer EG (2011) Monocyte recruitment during infection and
inflammation. Nat Rev Immunol 11: 762–774.
38. Qiu WQ, Ye Z, Kholodenko D, Seubert P, Selkoe DJ (1997) Degradation of
amyloid beta-protein by a metalloprotease secreted by microglia and other
neural and non-neural cells. J Biol Chem 272: 6641–6646.
39. Paresce DM, Ghosh RN, Maxfield FR (1996) Microglial cells internalize
aggregates of the Alzheimer’s disease amyloid beta-protein via a scavenger
receptor. Neuron 17: 553–565.
40. Mildner A, Djukic M, Garbe D, Wellmer A, Kuziel WA, et al. (2008) Ly-
6G+CCR2- myeloid cells rather than Ly-6ChighCCR2+ monocytes are
required for the control of bacterial infection in the central nervous system.
J Immunol 181: 2713–2722.
41. Mildner A, Mack M, Schmidt H, Bruck W, Djukic M, et al. (2009) CCR2+Ly-
6Chi monocytes are crucial for the effector phase of autoimmunity in the central
nervous system. Brain 132: 2487–2500.
42. Simard AR, Rivest S (2004) Bone marrow stem cells have the ability to populate
the entire central nervous system into fully differentiated parenchymal microglia.
Faseb J 18: 998–1000.
43. Naert G, Rivest S (2012) Hematopoietic CC-chemokine receptor 2 (CCR2)
competent cells are protective for the cognitive impairments and amyloid
pathology in a transgenic mouse model of Alzheimer’s disease. Mol Med 18:
297–313.
44. Graber DJ, Hickey WF, Harris BT (2010) Progressive changes in microglia and
macrophages in spinal cord and peripheral nerve in the transgenic rat model of
amyotrophic lateral sclerosis. J Neuroinflammation 7: 8.
45. Biju K, Zhou Q, Li G, Imam SZ, Roberts JL, et al. (2010) Macrophage-
mediated GDNF delivery protects against dopaminergic neurodegeneration: a
therapeutic strategy for Parkinson’s disease. Mol Ther 18: 1536–1544.
46. Hendriks JJ, Teunissen CE, de Vries HE, Dijkstra CD (2005) Macrophages and
neurodegeneration. Brain Res Brain Res Rev 48: 185–195.
47. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, et al. (2010)
Development of monocytes, macrophages, and dendritic cells. Science 327: 656–
661.
48. Templeton SP, Kim TS, O’Malley K, Perlman S (2008) Maturation and
localization of macrophages and microglia during infection with a neurotropic
murine coronavirus. Brain Pathol 18: 40–51.
49. Dalmau I, Vela JM, Gonzalez B, Finsen B, Castellano B (2003) Dynamics of
microglia in the developing rat brain. J Comp Neurol 458: 144–157.
50. Kent LM, Smyth LJ, Plumb J, Clayton CL, Fox SM, et al. (2009) Inhibition of
lipopolysaccharide-stimulated chronic obstructive pulmonary disease macro-
phage inflammatory gene expression by dexamethasone and the p38 mitogen-
activated protein kinase inhibitor N-cyano-N’-(2-{[8-(2,6-difluorophenyl)-4-(4-
fluoro-2-methylphenyl)-7-oxo-7,8-dihy dropyrido[2,3-d] pyrimidin-2-yl]ami-
no}ethyl)guanidine (SB706504). J Pharmacol Exp Ther 328: 458–468.
51. Smythies LE, White CR, Maheshwari A, Palgunachari MN, Anantharamaiah
GM, et al. (2010) Apolipoprotein A-I mimetic 4F alters the function of human
monocyte-derived macrophages. Am J Physiol Cell Physiol 298: C1538–1548.
52. Delpedro AD, Barjavel MJ, Mamdouh Z, Faure S, Bakouche O (1998) Signal
transduction in LPS-activated aged and young monocytes. J Interferon Cytokine
Res 18: 429–437.
53. Clark JA, Peterson TC (1994) Cytokine production and aging: overproduction of
IL-8 in elderly males in response to lipopolysaccharide. Mech Ageing Dev 77:
127–139.
54. Mariani E, Pulsatelli L, Neri S, Dolzani P, Meneghetti A, et al. (2002) RANTES
and MIP-1alpha production by T lymphocytes, monocytes and NK cells from
nonagenarian subjects. Exp Gerontol 37: 219–226.
55. Kaplin A, Carroll KA, Cheng J, Allie R, Lyketsos CG, et al. (2009) IL-6 release
by LPS-stimulated peripheral blood mononuclear cells as a potential biomarker
in Alzheimer’s disease. Int Psychogeriatr 21: 413–414.
56. Gallagher JJ, Finnegan ME, Grehan B, Dobson J, Collingwood JF, et al. (2012)
Modest Amyloid Deposition is Associated with Iron Dysregulation, Microglial
Activation, and Oxidative Stress. J Alzheimers Dis 28: 147–161.
57. Xie L, Yamasaki T, Ichimaru N, Yui J, Kawamura K, et al. (2012) [(11)C]DAC-
PET for noninvasively monitoring neuroinflammation and immunosuppressive
therapy efficacy in rat experimental autoimmune encephalomyelitis model.
J Neuroimmune Pharmacol 7: 231–242.
58. Moreira AP, Hogaboam CM (2011) Macrophages in allergic asthma: fine-tuning
their pro- and anti-inflammatory actions for disease resolution. J Interferon
Cytokine Res 31: 485–491.
59. Orme J, Mohan C (2012) Macrophage subpopulations in systemic lupus
erythematosus. Discov Med 13: 151–158.
60. Wilcock DM (2012) A changing perspective on the role of neuroinflammation in
Alzheimer’s disease. Int J Alzheimers Dis 2012: 495243.
61. van Duin D, Mohanty S, Thomas V, Ginter S, Montgomery RR, et al. (2007)
Age-associated defect in human TLR-1/2 function. J Immunol 178: 970–975.
62. Reed-Geaghan EG, Reed QW, Cramer PE, Landreth GE (2010) Deletion of
CD14 attenuates Alzheimer’s disease pathology by influencing the brain’s
inflammatory milieu. J Neurosci 30: 15369–15373.
63. Michaud JP, Richard KL, Rivest S (2011) MyD88-adaptor protein acts as a
preventive mechanism for memory deficits in a mouse model of Alzheimer’s
disease. Mol Neurodegener 6: 5.
64. Reed-Geaghan EG, Savage JC, Hise AG, Landreth GE (2009) CD14 and toll-
like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial
activation. J Neurosci 29: 11982–11992.
65. Zhang W, Wang LZ, Yu JT, Chi ZF, Tan L (2012) Increased expressions of
TLR2 and TLR4 on peripheral blood mononuclear cells from patients with
Alzheimer’s disease. J Neurol Sci 315: 67–71.
Inflammatory Changes in MDMs from LPs
PLOS ONE | www.plosone.org 8 May 2013 | Volume 8 | Issue 5 | e63194
